{"id":"W4309487094","doi":"10.1016/s1474-4422(22)00446-x","title":"Ublituximab: a new anti-CD20 agent for multiple sclerosis","year":2022,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Ocrelizumab; Ofatumumab; Teriflunomide; Medicine; Multiple sclerosis; Web of science; Daclizumab; Rituximab; Dermatology; Internal medicine; Fingolimod; Monoclonal antibody; Immunology; Antibody; Lymphoma; Meta-analysis","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002322487,0.0003509264,0.0006188022,0.0005375223,0.0002664169,0.0008580937,0.0003710453,0.0008519244,0.00360713],"category_scores_gemma":[0.00162716,0.0001670306,0.0005121876,0.0003827758,0.0003192011,0.000944795,0.0004343664,0.001298012,0.0004030506],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001258152,"about_ca_system_score_gemma":0.0009801857,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002624905,"about_ca_topic_score_gemma":0.008716298,"domain_scores_codex":[0.9993449,0.0003003215,0.00005057854,0.00006459254,0.0001533992,0.00008611818],"domain_scores_gemma":[0.9993713,0.0002019844,0.0001305605,0.00002936529,0.00008172171,0.0001850827],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.1124024,0.002618526,0.009574699,0.004879518,0.002554676,0.0003668226,0.0001827235,0.001166879,0.01914978,0.003094796,0.02852242,0.8154868],"study_design_scores_gemma":[0.2438223,0.1129631,0.1793879,0.003793611,0.01264439,0.002294117,0.0005865747,0.00338607,0.02422621,0.003613225,0.4130099,0.000272679],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.7084436,0.2403639,0.001399281,0.01414179,0.003292627,0.0008468651,0.0019269,0.0002371947,0.02934788],"genre_scores_gemma":[0.9292685,0.04423506,0.003124123,0.005524796,0.0005164756,0.0003708618,0.001672627,0.00002916937,0.01525842],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00360713,"threshold_uncertainty_score":0.01228261,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2183592580892287,"score_gpt":0.341899105275114,"score_spread":0.1235398471858852,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}